Fernanda Orsi Explores Brazilian Registry of Thrombotic Thrombocytopenic Purpura
Fernanda Orsi, Associate Professor at Faculty of Medical Sciences, Unicamp, shared on LinkedIn:
”I am always happy to share my work and new insightful publications.
However, this one comes with a bitter taste.
In this prospective study, we show that the diagnosis and treatment of thrombotic thrombocytopenic purpura (TTP) in Brazil are more than 10 years outdated, negatively affecting disease prognosis.
Forty percent of patients don’t have access to ADAMTS13 testing; more than 10% don’t receive therapeutic plasma exchange, and half don’t receive rituximab.
In-hospital mortality is high (15%). TTP management is still challenging in Brazil, as it likely is in other low- and middle-income countries.
It is difficult to look at these numbers and not call for action, both to promote medical education for earlier recognition of the disease and to improve access to appropriate healthcare.”
Read the full article here.
Article: Brazilian Registry of Thrombotic Thrombocytopenic Purpura: A prospective cohort study of diagnosis, management and outcomes in Brazil
Authors: Thaís Nóbrega, Tiago Boechat, Denys Fujimoto, Sibia Marcondes, Silvia Bueno, Suzanna Tavares, Alessandra Prezotti, Juliana Duarte, Fabiana Piassi, Lucas Cesped, Erica Okazaki, Bianca Stefanello, Carolina Costa-Lima, Paula Villaça, Fernanda Orsi
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 28, 2026, 13:46Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
-
Jul 28, 2026, 13:22Raelene Kambli: Advocating for Safer Blood Access
-
Jul 28, 2026, 13:07Connie Montgomery: Conversations That Change Hemophilia Care
-
Jul 28, 2026, 09:06Payal Desai: Highlights from the NASCC 2026 Sickle Cell Workshop
-
Jul 28, 2026, 08:43Flora Peyvandi։ Acquired Hemophilia A – An Illustrated Review Based on French Guidelines
-
Jul 28, 2026, 08:28Ujjal Didar Singh Sekhon: Exploring SynthoPlate Under P2Y12 Blockade
-
Jul 28, 2026, 08:27Sujeet Katiyar: You Share Patient Data with Your TPA. Where Is the Contract?
-
Jul 28, 2026, 07:50Mihail Celeski: Personalizing Anticoagulant Therapy for Frail Patients With Atrial Fibrillation
-
Jul 28, 2026, 07:36Ifeanyichukwu Ifechidere: What If the Test We’ve Trusted for Decades Has Been Telling Us Half the Story?